CUSIP No. 82835W 10 8 | 13G | Exhibit 99.1 |
JOINT FILING STATEMENT
We, the undersigned, hereby express our agreement that the attached statement on Schedule 13G relating to the Common Stock of Silverback Therapeutics, Inc. is filed on behalf of each of us.
Dated: February 16, 2021
Nextech VI Oncology SCSp
By: | Nextech VI GP S.à r.l. |
Its: | General Partner |
By: | /s/ Dalia Bleyer | |
Dalia Bleyer, Managing Member | ||
By: | /s/ Rocco Sgobbo | |
Rocco Sgobbo, Managing Member |
Nextech VI GP S.à r.l. | ||
By: | /s/ Dalia Bleyer | |
Dalia Bleyer, Managing Member | ||
By: | /s/ Rocco Sgobbo | |
Rocco Sgobbo, Managing Member |
/s/ Rocco Sgobbo | |
Rocco Sgobbo | |
/s/ Dalia Bleyer | |
Dalia Bleyer | |
/s/ Ian Charoub | |
Ian Charoub |